Akademik Veri Yönetim Sistemi
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, cilt.20, sa.3, ss.258-260, 2010 (SCI-Expanded, Scopus, TRDizin)
Atomoxetine, a selective norepinephrine inhibitor, was introduced as a safe non-stimulant alternative treatment for attention deficit hyperactivity disorder. In the clinical practice common side effects of atomoxetine are headache, abdominal pain, decreased appetite, fatigue, nausea, vomiting and dizziness. Here, we present an adolescent male who developed diffuse alopecia under atomoxetine treatment with no personal and family history of alopecia. To our knowledge, this is the second report of a causal connection between atomoxetine intake and hair loss.